Hope and anxiety surround new Alzheimer’s drug lecanemab

Two pharmaceutical companies say a drug they’ve developed has the potential to slow the progression of Alzheimer’s, something no treatment has been able to do. Now, researchers and those impacted by the disease are anxiously awaiting the full results of a human trial for the medication.